Market Overview:
The global acute sensorineural hearing loss treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of acute sensorineural hearing loss, rising awareness about the available treatments, and technological advancements in the field of hearing aids and cochlear implants. The global acute sensorineural hearing loss treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into systemic steroids, antiviral medication, vasodilators, carbogen therapy (95% oxygen and 5% carbon dioxide), and others (including hyperbaric oxygen therapy). On the basis of application, hospitals accounted for a major share in 2017 owing to increased prevalence of chronic diseases such as diabetes mellitus and hypertension that lead to sudden onset deafness or significant deterioration in auditory function. However, otology clinics are expected to witness highest growth during 2018-2030 owing to increasing demand for advanced diagnostic procedures such as otoacoustic emissions testing (OAE) and auditory brainstem response testing (ABR).
Product Definition:
Sensorineural hearing loss is a type of permanent hearing loss that is caused by damage to the inner ear, the auditory nerve, or the parts of the brain that control hearing. Acute sensorineural hearing loss treatment refers to any medical or surgical interventions used to improve or restore lost Hearing in individuals with this condition. While there is no cure for sensorineural hearing loss, early diagnosis and treatment can often help improve patients' quality of life and ability to communicate.
Systemic Steroids:
Systemic steroids are corticosteroids that are produced in the human body. They are used to reduce inflammation and swelling, and to help repair damaged tissues. Systemic steroids can be given by mouth, injected into a vein or they may be placed in the stomach using an oral preparation. The most commonly used systemic steroids include methylprednisolone, betamethasone sodium phosphate, dexamethasone sodium phosphate and fluorometholone (Furadantin).
Antiviral Medication:
Antiviral medication and it's usage in the acute sensorineural hearing loss treatment market is a study analyzing the current trends of the antiviral medications used for ASHL treatment. The main objective of this study is to provide complete information about these drugs to healthcare professionals so that they can prescribe an appropriate medication for ASHL related problems.
Application Insights:
The others segment held the largest share of the acute sensorineural hearing loss treatment market in 2017. This is due to a rise in incidence of other causes of hearing loss such as trauma, noise-induced hearing loss and ototoxic drugs. Moreover, increasing awareness about these treatments among patients is expected to boost demand over the forecast period.
Hospital based clinics are estimated to register the fastest CAGR during the forecast period owing to factors such as an increase in prevalence and complexity of cases requiring acute sensorineural hearing loss treatment along with growing government initiatives for improving healthcare infrastructure across various regions globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of age-related hearing loss, increasing awareness about early diagnosis, and availability of highly effective treatment methods for both acute and chronic forms of sensorineural hearing loss. Moreover, favorable reimbursement policies are also expected to contribute towards growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and rising disposable income levels in emerging countries such as China & India. In addition, an increase in foreign direct investments by international players is anticipated to boost industry expansion over this region during the same period.
Growth Factors:
- Increasing incidence of acute sensorineural hearing loss (ASHL) due to various reasons such as aging, exposure to loud noise, and viral infections is expected to drive the ASHL treatment market growth.
- Rising demand for novel and advanced ASHL treatments is another key factor that is anticipated to fuel the market growth in the coming years.
- Growing number of ENT clinics and hospitals worldwide is also projected to boost the ASHL treatment market in near future.
- increasing research funding for development of new therapies for ASHL would provide lucrative opportunities for players operating in this market during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Acute Sensorineural Hearing Loss Treatment Market Research Report
By Type
Systemic Steroids, Antiviral Medication, Vasodilators, Carbogen Therapy, Others
By Application
Hospitals, Otology Clinics, Ambulatory Clinics
By Companies
Pfizer, Bristol-Myers Squibb Company, Allergan, Renate pharmaceutical, Merck, F. Hoffmann-La Roche, Eli Lilly and Company, Novartis, GlaxoSmithKline, Teva pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Acute Sensorineural Hearing Loss Treatment Market Report Segments:
The global Acute Sensorineural Hearing Loss Treatment market is segmented on the basis of:
Types
Systemic Steroids, Antiviral Medication, Vasodilators, Carbogen Therapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Otology Clinics, Ambulatory Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Bristol-Myers Squibb Company
- Allergan
- Renate pharmaceutical
- Merck
- F. Hoffmann-La Roche
- Eli Lilly and Company
- Novartis
- GlaxoSmithKline
- Teva pharmaceuticals
Highlights of The Acute Sensorineural Hearing Loss Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Systemic Steroids
- Antiviral Medication
- Vasodilators
- Carbogen Therapy
- Others
- By Application:
- Hospitals
- Otology Clinics
- Ambulatory Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acute Sensorineural Hearing Loss Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acute sensorineural hearing loss (ASHL) is a temporary condition that results from damage to the inner ear. The most common cause of AHL is exposure to loud noise. Treatment for AHL typically includes wearing earplugs or headphones at work or during leisure activities, and receiving counseling about safe noise levels.
Some of the major players in the acute sensorineural hearing loss treatment market are Pfizer, Bristol-Myers Squibb Company, Allergan, Renate pharmaceutical, Merck, F. Hoffmann-La Roche, Eli Lilly and Company, Novartis, GlaxoSmithKline, Teva pharmaceuticals.
The acute sensorineural hearing loss treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acute Sensorineural Hearing Loss Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acute Sensorineural Hearing Loss Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acute Sensorineural Hearing Loss Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acute Sensorineural Hearing Loss Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acute Sensorineural Hearing Loss Treatment Market Size & Forecast, 2018-2028
4.5.1 Acute Sensorineural Hearing Loss Treatment Market Size and Y-o-Y Growth
4.5.2 Acute Sensorineural Hearing Loss Treatment Market Absolute $ Opportunity
Chapter 5 Global Acute Sensorineural Hearing Loss Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Type
5.2.1 Systemic Steroids
5.2.2 Antiviral Medication
5.2.3 Vasodilators
5.2.4 Carbogen Therapy
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Acute Sensorineural Hearing Loss Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Otology Clinics
6.2.3 Ambulatory Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acute Sensorineural Hearing Loss Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Acute Sensorineural Hearing Loss Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Type
9.6.1 Systemic Steroids
9.6.2 Antiviral Medication
9.6.3 Vasodilators
9.6.4 Carbogen Therapy
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Otology Clinics
9.10.3 Ambulatory Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Acute Sensorineural Hearing Loss Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Type
10.6.1 Systemic Steroids
10.6.2 Antiviral Medication
10.6.3 Vasodilators
10.6.4 Carbogen Therapy
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Otology Clinics
10.10.3 Ambulatory Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Acute Sensorineural Hearing Loss Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Type
11.6.1 Systemic Steroids
11.6.2 Antiviral Medication
11.6.3 Vasodilators
11.6.4 Carbogen Therapy
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Otology Clinics
11.10.3 Ambulatory Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Acute Sensorineural Hearing Loss Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Type
12.6.1 Systemic Steroids
12.6.2 Antiviral Medication
12.6.3 Vasodilators
12.6.4 Carbogen Therapy
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Otology Clinics
12.10.3 Ambulatory Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Acute Sensorineural Hearing Loss Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Type
13.6.1 Systemic Steroids
13.6.2 Antiviral Medication
13.6.3 Vasodilators
13.6.4 Carbogen Therapy
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Acute Sensorineural Hearing Loss Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Otology Clinics
13.10.3 Ambulatory Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acute Sensorineural Hearing Loss Treatment Market: Competitive Dashboard
14.2 Global Acute Sensorineural Hearing Loss Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Bristol-Myers Squibb Company
14.3.3 Allergan
14.3.4 Renate pharmaceutical
14.3.5 Merck
14.3.6 F. Hoffmann-La Roche
14.3.7 Eli Lilly and Company
14.3.8 Novartis
14.3.9 GlaxoSmithKline
14.3.10 Teva pharmaceuticals
